{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:03:17Z","timestamp":1762642997332,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830014","91949201"],"award-info":[{"award-number":["81830014","91949201"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2020CFB429"],"award-info":[{"award-number":["2020CFB429"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"DOI":"10.1007\/s10557-024-07561-5","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T09:03:25Z","timestamp":1708074205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Isoimperatorin Inhibits Angiogenesis by Suppressing VEGFR2 Signaling Pathway"],"prefix":"10.1007","author":[{"given":"Yating","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4026-951X","authenticated-orcid":false,"given":"Minglu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"issue":"11","key":"7561_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/s41419-020-03161-x","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Ji X, Kang N, Zhou J, Liang X, Li J, et al. Tumor necrosis factor alpha inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer. Cell Death Dis. 2020;11(11):993.","journal-title":"Cell Death Dis"},{"issue":"7","key":"7561_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S2468-1253(21)00109-6","volume":"6","author":"S Qin","year":"2021","unstructured":"Qin S, Li Q, Gu S, Chen X, Lin L, Wang Z, et al. Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2021;6(7):559\u201368.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7561_CR3","doi-asserted-by":"crossref","unstructured":"Peach CJ, Mignone VW, Arruda MA, Alcobia DC, Hill SJ, Kilpatrick LE et al. Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2. Int J Mol Sci. 2018;19(4).","DOI":"10.3390\/ijms19041264"},{"issue":"10","key":"7561_CR4","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrm.2016.87","volume":"17","author":"M Simons","year":"2016","unstructured":"Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol. 2016;17(10):611\u201325.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7561_CR5","doi-asserted-by":"publisher","first-page":"112664","DOI":"10.1016\/j.jep.2020.112664","volume":"256","author":"HD Cho","year":"2020","unstructured":"Cho HD, Lee KW, Won YS, Kim JH, Seo KI. Cultivated orostachys japonicus extract inhibits VEGF-induced angiogenesis via regulation of VEGFR2 signaling pathway in vitro and in vivo. J Ethnopharmacol. 2020;256:112664.","journal-title":"J Ethnopharmacol"},{"key":"7561_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3389\/fphar.2019.00764","volume":"10","author":"J Li","year":"2019","unstructured":"Li J, Peng J, Zhao S, Zhong Y, Wang Y, Hu J, et al. Tussilagone suppresses angiogenesis by inhibiting the VEGFR2 Signaling Pathway. Front Pharmacol. 2019;10:764.","journal-title":"Front Pharmacol"},{"issue":"3","key":"7561_CR7","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1142\/S0192415X18500295","volume":"46","author":"GS Zhu","year":"2018","unstructured":"Zhu GS, Tang LY, Lv DL, Jiang M. Total flavones of Abelmoschus manihot exhibits pro-angiogenic activity by activating the VEGF-A\/VEGFR2-PI3K\/Akt Signaling Axis. Am J Chin Med. 2018;46(3):567\u201383.","journal-title":"Am J Chin Med"},{"issue":"6","key":"7561_CR8","doi-asserted-by":"publisher","first-page":"9636","DOI":"10.3892\/mmr.2017.7777","volume":"16","author":"J Ouyang","year":"2017","unstructured":"Ouyang J, Jiang H, Fang H, Cui W, Cai D. Isoimperatorin ameliorates osteoarthritis by downregulating the mammalian target of rapamycin C1 signaling pathway. Mol Med Rep. 2017;16(6):9636\u201344.","journal-title":"Mol Med Rep"},{"issue":"11","key":"7561_CR9","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1002\/ptr.6726","volume":"34","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang Y, Zeng Y, Ge S, Sun X, Jia M, et al. Isoimperatorin reduces the effective dose of dexamethasone in a murine model of asthma by inhibiting mast cell activation. Phytother Res. 2020;34(11):2985\u201397.","journal-title":"Phytother Res"},{"key":"7561_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.intimp.2017.05.012","volume":"49","author":"CUB Wijerathne","year":"2017","unstructured":"Wijerathne CUB, Seo CS, Song JW, Park HS, Moon OS, Won YS, et al. Isoimperatorin attenuates airway inflammation and mucus hypersecretion in an ovalbumin-induced murine model of asthma. Int Immunopharmacol. 2017;49:67\u201376.","journal-title":"Int Immunopharmacol"},{"key":"7561_CR11","doi-asserted-by":"publisher","first-page":"657826","DOI":"10.3389\/fphar.2021.657826","volume":"12","author":"Y Lai","year":"2021","unstructured":"Lai Y, Han T, Zhan S, Jiang Y, Liu X, Li G. Antiviral activity of Isoimperatorin against Influenza A Virus in vitro and its inhibition of neuraminidase. Front Pharmacol. 2021;12:657826.","journal-title":"Front Pharmacol"},{"issue":"1","key":"7561_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3892\/ol.2016.5387","volume":"13","author":"K Tong","year":"2017","unstructured":"Tong K, Xin C, Chen W. Isoimperatorin induces apoptosis of the SGC-7901 human gastric cancer cell line via the mitochondria-mediated pathway. Oncol Lett. 2017;13(1):518\u201324.","journal-title":"Oncol Lett"},{"issue":"5","key":"7561_CR13","first-page":"7993","volume":"15","author":"HB Yang","year":"2018","unstructured":"Yang HB, Gao HR, Ren YJ, Fang FX, Tian HT, Gao ZJ, et al. Effects of isoimperatorin on proliferation and apoptosis of human gastric carcinoma cells. Oncol Lett. 2018;15(5):7993\u20138.","journal-title":"Oncol Lett"},{"issue":"3","key":"7561_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nprot.2007.54","volume":"2","author":"B Baudin","year":"2007","unstructured":"Baudin B, Bruneel A, Bosselut N, Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc. 2007;2(3):481\u20135.","journal-title":"Nat Protoc"},{"issue":"4","key":"7561_CR15","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1210\/er.2003-0027","volume":"25","author":"N Ferrara","year":"2004","unstructured":"Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004;25(4):581\u2013611.","journal-title":"Endocr Rev"},{"issue":"9","key":"7561_CR16","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1172\/JCI126655","volume":"129","author":"A Rattner","year":"2019","unstructured":"Rattner A, Williams J, Nathans J. Roles of HIFs and VEGF in angiogenesis in the retina and brain. J Clin Invest. 2019;129(9):3807\u201320.","journal-title":"J Clin Invest"},{"issue":"3","key":"7561_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10456-009-9146-4","volume":"12","author":"I Arnaoutova","year":"2009","unstructured":"Arnaoutova I, George J, Kleinman HK, Benton G. The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis. 2009;12(3):267\u201374.","journal-title":"Angiogenesis"},{"key":"7561_CR18","doi-asserted-by":"publisher","first-page":"113690","DOI":"10.1016\/j.expneurol.2021.113690","volume":"341","author":"Y Zhong","year":"2021","unstructured":"Zhong Y, Yin B, Ye Y, Dekhel O, Xiong X, Jian Z, et al. The bidirectional role of the JAK2\/STAT3 signaling pathway and related mechanisms in cerebral ischemia-reperfusion injury. Exp Neurol. 2021;341:113690.","journal-title":"Exp Neurol"},{"key":"7561_CR19","doi-asserted-by":"publisher","first-page":"599281","DOI":"10.3389\/fcell.2020.599281","volume":"8","author":"X Wang","year":"2020","unstructured":"Wang X, Bove AM, Simone G, Ma B. Molecular bases of VEGFR-2-Mediated physiological function and pathological role. Front Cell Dev Biol. 2020;8:599281.","journal-title":"Front Cell Dev Biol"},{"issue":"13","key":"7561_CR20","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.2174\/0929867327666200514082425","volume":"28","author":"K Cheng","year":"2021","unstructured":"Cheng K, Liu CF, Rao GW. Anti-angiogenic agents: a review on vascular endothelial growth factor Receptor-2 (VEGFR-2) inhibitors. Curr Med Chem. 2021;28(13):2540\u201364.","journal-title":"Curr Med Chem"},{"issue":"11","key":"7561_CR21","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.1096\/fj.14-256206","volume":"28","author":"S Manni","year":"2014","unstructured":"Manni S, Kisko K, Schleier T, Missimer J, Ballmer-Hofer K. Functional and structural characterization of the kinase insert and the carboxy terminal domain in VEGF receptor 2 activation. FASEB J. 2014;28(11):4914\u201323.","journal-title":"FASEB J"},{"key":"7561_CR22","doi-asserted-by":"publisher","first-page":"115502","DOI":"10.1016\/j.bcp.2023.115502","volume":"211","author":"H Li","year":"2023","unstructured":"Li H, Deng W, Qin Q, Lin Y, Liu T, Mo G, et al. Isoimperatorin attenuates bone loss by inhibiting the binding of RANKL to RANK. Biochem Pharmacol. 2023;211:115502.","journal-title":"Biochem Pharmacol"},{"key":"7561_CR23","doi-asserted-by":"publisher","first-page":"119291","DOI":"10.1016\/j.lfs.2021.119291","volume":"274","author":"T Ma","year":"2021","unstructured":"Ma T, Liu P, Wei J, Zhao M, Yao X, Luo X, et al. Imperatorin alleviated endometriosis by inhibiting the activation of PI3K\/Akt\/NF-kappaB pathway in rats. Life Sci. 2021;274:119291.","journal-title":"Life Sci"},{"key":"7561_CR24","doi-asserted-by":"publisher","first-page":"104871","DOI":"10.1016\/j.phrs.2020.104871","volume":"158","author":"L Chen","year":"2020","unstructured":"Chen L, Xu W, Yang Q, Zhang H, Wan L, Xin B, et al. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3. Pharmacol Res. 2020;158:104871.","journal-title":"Pharmacol Res"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07561-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-024-07561-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07561-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T09:20:56Z","timestamp":1708075256000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-024-07561-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":24,"alternative-id":["7561"],"URL":"https:\/\/doi.org\/10.1007\/s10557-024-07561-5","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"assertion":[{"value":"7 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for all animal experimental procedures was obtained from the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (permit number: [2023] IACUC Number 3393). All animal experimental procedures were conducted in strict adherence to applicable institutional and national regulations and guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}